Clinical trials offer a slew of benefits: optimal dosage ranges, identified potential side effects, and efficacy data. If approved by the FDA, clinicians leverage the insights from Phase III trials to ...

Pharmacogenomics (PGx), the study of how genetic profiles impact an individual’s responses to medication, has already begun to help healthcare providers (HCPs) optimize care through its capacity to ...

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system investigates the multifaceted implementation of pharmacogenomics—a rapidly evolving field ...

Atomoxetine CYP2D6 Recommended for evaluating patients' metabolizing rates Information only Venlafaxine CYP2D6 Recommended for evaluating patients' metabolizing rates Information only Risperidone ...

Prostate cancer (PC) stands as the second leading cause of death among American men, with about 1 in 8 men diagnosed during their lifetime. PC is categorized into four main types based on disease ...

NEW YORK--(BUSINESS WIRE)--Igentify, a digital health company alleviating bottlenecks in the genetic testing process, announced the launch of its Non-Invasive Prenatal Testing (NIPT) and ...

Our Pharmacogenomics and Transport micro-credential is a three-course series encompassing several aspects of pharmacogenomics from transport to current events incorporating cancer and nutrition. Each ...

VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that its ...